Viaderma (VDRM) Stock Price

Viaderma Price

OTC·CLOSED
0.00
​
Market closed

Over the last 17 years Viaderma grew revenue by 20.1% annually, reaching 450,500.00 USD. Earnings per share have declined at 67.5% per year over the last 15 years. For Viaderma, the net margin of -858.6% is down versus 16.2% a few years ago.

Viaderma stock price

Access this data via the Eulerpool API

Viaderma business model & stock analysis

ViaDerma, Inc. is engaged in the manufacturing and sales of pharmaceutical related products. The company is headquartered in Marina Del Rey, California and currently employs 75 full-time employees. The company went IPO on 2008-06-10. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. In addition to licensing its proprietary transdermal technologies, its lead product, Vitastem, is available for treating multiple skin conditions and ailments. The firm also has products in development in fields, such as anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.

Frequently asked questions about Viaderma

Converted at the current exchange rate, the Viaderma share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Viaderma.

The profit cannot currently be calculated for Viaderma.

The P/E ratio cannot be calculated for Viaderma at the moment.

The P/S cannot be calculated for Viaderma currently.

The Eulerpool Quality Score for Viaderma is 1/10.

The ISIN of Viaderma is US92555K1016. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Viaderma is A113TU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Viaderma is VDRM. The ticker symbol is used to trade Viaderma shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
6,006.67 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jun 10, 2008
ISIN
US92555K1016
Cusip
92555K101
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-178.35 %
Last updated Oct 10, 2026, 6:12 PM

Viaderma Peer Group

Viaderma Ticker

OTC · VDRM

Viaderma FIGI

VDRM:US · BBG000JN17K9VDRM:PQ · BBG000JN1FW8VDRM:UV · BBG000JN1H27

All fundamentals and in-depth analysis of Viaderma

Our stock analysis for Viaderma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Viaderma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.